MHRA Response to contaminated paediatric medicines
On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.
On the 7th of October The Medicines and Healthcare products Regulatory Agency (MHRA) released a response to contaminated paediatric medicines identified by the WHO region of Africa.
What makes a good RP? – The Responsible Person (RP) title is the named person on a Wholesale Distribution Authorisation (WDA).
Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi
The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…
It is essential that the whole team understands what those guidelines are and why it is so important to work in them.